USE OF TCR Vβ2 REPERTOIRES TO DIFFERENTIATE CD8 T-CELL LYMPHOMAS FROM INFECTIOUS DISEASE REACTIVE LYMPHOCYTOSIS
Lido
2743
Vezesque se leu este artigo
973
Total PDF
1770
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 39 | 8 | 47 |
| 2025 5 | 86 | 19 | 105 |
| 2025 4 | 66 | 19 | 85 |
| 2025 3 | 80 | 23 | 103 |
| 2025 2 | 52 | 26 | 78 |
| 2025 1 | 45 | 41 | 86 |
| 2024 12 | 39 | 27 | 66 |
| 2024 11 | 39 | 33 | 72 |
| 2024 10 | 41 | 22 | 63 |
| 2024 9 | 53 | 23 | 76 |
| 2024 8 | 68 | 52 | 120 |
| 2024 7 | 38 | 34 | 72 |
| 2024 6 | 60 | 31 | 91 |
| 2024 5 | 58 | 54 | 112 |
| 2024 4 | 44 | 24 | 68 |
| 2024 3 | 49 | 24 | 73 |
| 2024 2 | 38 | 27 | 65 |
| 2024 1 | 39 | 18 | 57 |
| 2023 12 | 35 | 20 | 55 |
| 2023 11 | 50 | 24 | 74 |
| 2023 10 | 36 | 25 | 61 |
| 2023 9 | 38 | 28 | 66 |
| 2023 8 | 33 | 12 | 45 |
| 2023 7 | 42 | 11 | 53 |
| 2023 6 | 37 | 9 | 46 |
| 2023 5 | 41 | 16 | 57 |
| 2023 4 | 27 | 9 | 36 |
| 2023 3 | 21 | 11 | 32 |
| 2023 2 | 27 | 17 | 44 |
| 2023 1 | 24 | 5 | 29 |
| 2022 12 | 37 | 14 | 51 |
| 2022 11 | 36 | 20 | 56 |
| 2022 10 | 45 | 22 | 67 |
| 2022 9 | 38 | 20 | 58 |
| 2022 8 | 28 | 17 | 45 |
| 2022 7 | 28 | 26 | 54 |
| 2022 6 | 33 | 21 | 54 |
| 2022 5 | 27 | 22 | 49 |
| 2022 4 | 30 | 25 | 55 |
| 2022 3 | 31 | 21 | 52 |
| 2022 2 | 18 | 13 | 31 |
| 2021 1 | 23 | 13 | 36 |
| 2021 12 | 23 | 19 | 42 |
| 2021 11 | 18 | 19 | 37 |
| 2021 10 | 10 | 9 | 19 |
Mostrar tudo
